Aligned with
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.
This track focuses on the latest discoveries in the immunological responses to HIV infection. Researchers will present findings on immune evasion mechanisms and the role of T cells in controlling viral replication.
This session will explore cutting-edge vaccine platforms and technologies aimed at eliciting robust immune responses against HIV. Discussions will include mRNA vaccines, viral vectors, and nanoparticle-based approaches.
This track emphasizes the translation of basic immunological research into effective HIV vaccine candidates. Presentations will highlight successful case studies and ongoing clinical trials.
This session will delve into the complexities of the immune response during HIV infection, including the roles of antibodies and cellular immunity. Researchers will discuss the implications of these dynamics for vaccine design.
This track will focus on the role of adjuvants in enhancing the immunogenicity of HIV vaccines. Presentations will cover novel adjuvant systems and their mechanisms of action in promoting immune responses.
This session will explore the potential of immunotherapeutic strategies in the management of HIV/AIDS. Topics will include immune checkpoint inhibitors and therapeutic vaccines aimed at boosting immune control.
This track will address the design and execution of clinical trials for HIV vaccine candidates, highlighting regulatory hurdles and ethical considerations. Experts will share insights on best practices and lessons learned.
This session will investigate the mechanisms underlying immune memory in the context of HIV infection and vaccination. Researchers will discuss strategies to enhance durable immune responses.
This track will focus on the mechanisms of pathogen recognition and subsequent immune activation in HIV. Presentations will highlight the role of pattern recognition receptors and their implications for vaccine development.
This session will explore the genetic factors influencing susceptibility and resistance to HIV infection. Discussions will include the role of host genetics in shaping immune responses and vaccine efficacy.
This track will provide a platform for discussing emerging trends and future directions in HIV vaccine research. Experts will share their visions for innovative strategies to combat HIV/AIDS globally.